Latest News and Press Releases
Want to stay updated on the latest news?
-
Neurona Therapeutics Raises $102 Million to Fuel NRTX-1001 Phase 3 EPIC Epilepsy Trial and Advance Regenerative Cell Therapy Pipeline
-
Neurona Therapeutics Presents Positive Clinical Update: New Data from NRTX-1001 Cell Therapy Trial in Drug-resistant Epilepsy Announced at 2024 Annual Meet
-
Neurona Therapeutics Announces Participation in Upcoming Investor Conferences in October
-
Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy Candidate
-
Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs
-
Neurona Therapeutics Appoints Dr. Manher Joshi as Chief Medical Officer
-
Neurona Therapeutics to Participate in Jefferies Global Healthcare Conference